ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
Nature of Financial Relationships
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial relationships with ineligible companies any financial or other relationship(s) with an ineligible company including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speaker's bureau, symposia, and expert witness
- Independent contractor
- Ownership interest
- Royalties
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Other financial or material support
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
View ACR's ACCME disclosure practices
2023 disclosures coming soon
See 2022 disclosures in the 2022 meeting section below.